# MYRIAD GENETICS INC > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:22376a27-8a83-4b7a-8170-d37004d7898f | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/myriad-genetics-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 23 | | Claims under review | 1 | | Evidence records | 3 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-26T14:46:37.730209+00:00 | | Last reviewed | 2026-10-26T14:46:37.730209+00:00 | ## Identity - Legal name: MYRIAD GENETICS INC - Display name: MYRIAD GENETICS INC ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-26T19:37:57.745834+00:00 | | Completeness | 0.409 | | Record Quality | 0.826 | | Directors | 12 | | Committees | 1 | | Governance events | 7 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Colleen F. Reitan: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2019-01-01. claim_id=alpha:claim:company:22376a27-8a83-4b7a-8170-d37004d7898f:leadership_role:6 - Daniel M. Skovronsky: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2020-01-01. claim_id=alpha:claim:company:22376a27-8a83-4b7a-8170-d37004d7898f:leadership_role:7 - Heiner Dreismann: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2010-01-01. claim_id=alpha:claim:company:22376a27-8a83-4b7a-8170-d37004d7898f:leadership_role:9 - Lee N. Newcomer: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2019-01-01. claim_id=alpha:claim:company:22376a27-8a83-4b7a-8170-d37004d7898f:leadership_role:11 - Mark S. Davis: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2024-01-01. claim_id=alpha:claim:company:22376a27-8a83-4b7a-8170-d37004d7898f:leadership_role:13 - Paul M. Bisaro: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2022-01-01. claim_id=alpha:claim:company:22376a27-8a83-4b7a-8170-d37004d7898f:leadership_role:14 - Rashmi Kumar: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2020-01-01. claim_id=alpha:claim:company:22376a27-8a83-4b7a-8170-d37004d7898f:leadership_role:15 - Daniel M. Skovronsky, M.D., Ph.D.: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:22376a27-8a83-4b7a-8170-d37004d7898f:leadership_role:8 - Heiner Dreismann, Ph.D.: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:22376a27-8a83-4b7a-8170-d37004d7898f:leadership_role:10 - Lee N. Newcomer, M.D.: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:22376a27-8a83-4b7a-8170-d37004d7898f:leadership_role:12 - S. Louise Phanstiel: Chair of the Board. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:22376a27-8a83-4b7a-8170-d37004d7898f:leadership_role:5 - Samraat S. Raha: President, Chief Executive Officer and Director. Status: unknown. Independent: false. Since: NOT_PUBLISHED. Committees: Chief Executive Officer and Director (member). claim_id=alpha:claim:company:22376a27-8a83-4b7a-8170-d37004d7898f:leadership_role:16 ## Committees - Chief Executive Officer and Director (executive). Chair: NOT_PUBLISHED. Members: Samraat S. Raha (member, unknown). committee_id=alpha:committee:myriad-genetics-inc:chief-executive-officer-and-director ## Executive leadership - Benjamin R. Wheeler: Chief Financial Officer [CFO]. Status: unknown. claim_id=alpha:claim:company:22376a27-8a83-4b7a-8170-d37004d7898f:leadership_role:17 - Brian J. Donnelly: Chief Commercial Officer. Status: unknown. claim_id=alpha:claim:company:22376a27-8a83-4b7a-8170-d37004d7898f:leadership_role:18 - Dale Muzzey, Ph.D.: Chief Scientific Officer. Status: unknown. claim_id=alpha:claim:company:22376a27-8a83-4b7a-8170-d37004d7898f:leadership_role:19 - Jennifer Fox: Chief Legal Officer [GC]. Status: unknown. claim_id=alpha:claim:company:22376a27-8a83-4b7a-8170-d37004d7898f:leadership_role:20 - Mark S. Verratti: Chief Operating Officer [COO]. Status: unknown. claim_id=alpha:claim:company:22376a27-8a83-4b7a-8170-d37004d7898f:leadership_role:21 - Samraat S. Raha: President and Chief Executive Officer [CEO]. Status: unknown. claim_id=alpha:claim:company:22376a27-8a83-4b7a-8170-d37004d7898f:leadership_role:22 - Shereen Solaiman: Chief People Officer [CHRO]. Status: unknown. claim_id=alpha:claim:company:22376a27-8a83-4b7a-8170-d37004d7898f:leadership_role:23 ## Governance events - DIRECTOR_APPOINTED: Mark S. Davis seat on MYRIAD GENETICS INC, effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-26T14:46:37.730209+00:00. event_id=alpha:event:transition:c6qb4cgaxdi4 - DIRECTOR_APPOINTED: Paul M. Bisaro seat on MYRIAD GENETICS INC, effective 2022-01-01. Effective: 2022-01-01. Detected: 2026-10-26T14:46:37.730209+00:00. event_id=alpha:event:transition:4qepgp185ro45 - DIRECTOR_APPOINTED: Daniel M. Skovronsky seat on MYRIAD GENETICS INC, effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-26T14:46:37.730209+00:00. event_id=alpha:event:transition:1yk0ko77ysg3t - DIRECTOR_APPOINTED: Rashmi Kumar seat on MYRIAD GENETICS INC, effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-26T14:46:37.730209+00:00. event_id=alpha:event:transition:qrc4v2v9mcf2 - DIRECTOR_APPOINTED: Colleen F. Reitan seat on MYRIAD GENETICS INC, effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-26T14:46:37.730209+00:00. event_id=alpha:event:transition:2v86ga10u6bbi - DIRECTOR_APPOINTED: Lee N. Newcomer seat on MYRIAD GENETICS INC, effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-26T14:46:37.730209+00:00. event_id=alpha:event:transition:1fv7q3gy6iago - DIRECTOR_APPOINTED: Heiner Dreismann seat on MYRIAD GENETICS INC, effective 2010-01-01. Effective: 2010-01-01. Detected: 2026-10-26T14:46:37.730209+00:00. event_id=alpha:event:transition:1ssv5vkqcl2lk ## Scoped resources - `alpha://company/myriad-genetics-inc` (contract): https://registry.alpha.ac/api/public/companies/myriad-genetics-inc?format=record - `alpha://company/myriad-genetics-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/myriad-genetics-inc?format=record§ion=identity - `alpha://company/myriad-genetics-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/myriad-genetics-inc?format=record§ion=corporate-structure - `alpha://company/myriad-genetics-inc/board` (contract): https://registry.alpha.ac/api/public/companies/myriad-genetics-inc?format=record§ion=board - `alpha://company/myriad-genetics-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/myriad-genetics-inc?format=record§ion=committees - `alpha://company/myriad-genetics-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/myriad-genetics-inc?format=record§ion=leadership - `alpha://company/myriad-genetics-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/myriad-genetics-inc?format=record§ion=ownership - `alpha://company/myriad-genetics-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/myriad-genetics-inc?format=record§ion=financials - `alpha://company/myriad-genetics-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/myriad-genetics-inc?format=record§ion=capital-structure - `alpha://company/myriad-genetics-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/myriad-genetics-inc?format=record§ion=compensation - `alpha://company/myriad-genetics-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/myriad-genetics-inc?format=record§ion=governance - `alpha://company/myriad-genetics-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/myriad-genetics-inc?format=record§ion=shareholder-governance - `alpha://company/myriad-genetics-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/myriad-genetics-inc?format=record§ion=audit - `alpha://company/myriad-genetics-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/myriad-genetics-inc?format=record§ion=legal - `alpha://company/myriad-genetics-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/myriad-genetics-inc?format=record§ion=risk - `alpha://company/myriad-genetics-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/myriad-genetics-inc?format=record§ion=cyber - `alpha://company/myriad-genetics-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/myriad-genetics-inc?format=record§ion=ai-governance - `alpha://company/myriad-genetics-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/myriad-genetics-inc?format=record§ion=agents - `alpha://company/myriad-genetics-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/myriad-genetics-inc?format=record§ion=ecosystem - `alpha://company/myriad-genetics-inc/events` (contract): https://registry.alpha.ac/api/public/companies/myriad-genetics-inc?format=record§ion=events - `alpha://company/myriad-genetics-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/myriad-genetics-inc?format=record§ion=relationships - `alpha://company/myriad-genetics-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/myriad-genetics-inc?format=record§ion=assessments - `alpha://company/myriad-genetics-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/myriad-genetics-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - NO_RECORDS_FOUND ## Leadership - S. Louise Phanstiel: Chair of the Board. Claim: alpha:claim:company:22376a27-8a83-4b7a-8170-d37004d7898f:leadership_role:5. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:66cadeead084c313c84f4fe86874042b9630b955c0d6588becc96c5330ebfd95. - Colleen F. Reitan: Director. Claim: alpha:claim:company:22376a27-8a83-4b7a-8170-d37004d7898f:leadership_role:6. Valid from: 2019-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:a34701cba6c5217b2482a87529b1b599d7c36452c134b499989193f1e64826e3. - Daniel M. Skovronsky: Director. Claim: alpha:claim:company:22376a27-8a83-4b7a-8170-d37004d7898f:leadership_role:7. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:a34701cba6c5217b2482a87529b1b599d7c36452c134b499989193f1e64826e3. - Daniel M. Skovronsky, M.D., Ph.D.: Director. Claim: alpha:claim:company:22376a27-8a83-4b7a-8170-d37004d7898f:leadership_role:8. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:66cadeead084c313c84f4fe86874042b9630b955c0d6588becc96c5330ebfd95. - Heiner Dreismann: Director. Claim: alpha:claim:company:22376a27-8a83-4b7a-8170-d37004d7898f:leadership_role:9. Valid from: 2010-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:a34701cba6c5217b2482a87529b1b599d7c36452c134b499989193f1e64826e3. - Heiner Dreismann, Ph.D.: Director. Claim: alpha:claim:company:22376a27-8a83-4b7a-8170-d37004d7898f:leadership_role:10. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:66cadeead084c313c84f4fe86874042b9630b955c0d6588becc96c5330ebfd95. - Lee N. Newcomer: Director. Claim: alpha:claim:company:22376a27-8a83-4b7a-8170-d37004d7898f:leadership_role:11. Valid from: 2019-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:a34701cba6c5217b2482a87529b1b599d7c36452c134b499989193f1e64826e3. - Lee N. Newcomer, M.D.: Director. Claim: alpha:claim:company:22376a27-8a83-4b7a-8170-d37004d7898f:leadership_role:12. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:66cadeead084c313c84f4fe86874042b9630b955c0d6588becc96c5330ebfd95. - Mark S. Davis: Director. Claim: alpha:claim:company:22376a27-8a83-4b7a-8170-d37004d7898f:leadership_role:13. Valid from: 2024-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:a34701cba6c5217b2482a87529b1b599d7c36452c134b499989193f1e64826e3. - Paul M. Bisaro: Director. Claim: alpha:claim:company:22376a27-8a83-4b7a-8170-d37004d7898f:leadership_role:14. Valid from: 2022-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:a34701cba6c5217b2482a87529b1b599d7c36452c134b499989193f1e64826e3. - Rashmi Kumar: Director. Claim: alpha:claim:company:22376a27-8a83-4b7a-8170-d37004d7898f:leadership_role:15. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:a34701cba6c5217b2482a87529b1b599d7c36452c134b499989193f1e64826e3. - Samraat S. Raha: President, Chief Executive Officer and Director. Claim: alpha:claim:company:22376a27-8a83-4b7a-8170-d37004d7898f:leadership_role:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:66cadeead084c313c84f4fe86874042b9630b955c0d6588becc96c5330ebfd95. - Benjamin R. Wheeler: Chief Financial Officer. Claim: alpha:claim:company:22376a27-8a83-4b7a-8170-d37004d7898f:leadership_role:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:66cadeead084c313c84f4fe86874042b9630b955c0d6588becc96c5330ebfd95. - Brian J. Donnelly: Chief Commercial Officer. Claim: alpha:claim:company:22376a27-8a83-4b7a-8170-d37004d7898f:leadership_role:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:66cadeead084c313c84f4fe86874042b9630b955c0d6588becc96c5330ebfd95. - Dale Muzzey, Ph.D.: Chief Scientific Officer. Claim: alpha:claim:company:22376a27-8a83-4b7a-8170-d37004d7898f:leadership_role:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:66cadeead084c313c84f4fe86874042b9630b955c0d6588becc96c5330ebfd95. - Jennifer Fox: Chief Legal Officer. Claim: alpha:claim:company:22376a27-8a83-4b7a-8170-d37004d7898f:leadership_role:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:66cadeead084c313c84f4fe86874042b9630b955c0d6588becc96c5330ebfd95. - Mark S. Verratti: Chief Operating Officer. Claim: alpha:claim:company:22376a27-8a83-4b7a-8170-d37004d7898f:leadership_role:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:66cadeead084c313c84f4fe86874042b9630b955c0d6588becc96c5330ebfd95. - Samraat S. Raha: President and Chief Executive Officer. Claim: alpha:claim:company:22376a27-8a83-4b7a-8170-d37004d7898f:leadership_role:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:66cadeead084c313c84f4fe86874042b9630b955c0d6588becc96c5330ebfd95. - Shereen Solaiman: Chief People Officer. Claim: alpha:claim:company:22376a27-8a83-4b7a-8170-d37004d7898f:leadership_role:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:66cadeead084c313c84f4fe86874042b9630b955c0d6588becc96c5330ebfd95. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - PUBLISHED ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - MYRIAD GENETICS INC. Claim: alpha:claim:company:22376a27-8a83-4b7a-8170-d37004d7898f:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:f6234f630c14fa0b578bc5aa3215fa041f164fef4e76e54c3db8e79abd791ee1. ## Entity Status - Public listing published. Claim: alpha:claim:company:22376a27-8a83-4b7a-8170-d37004d7898f:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:f6234f630c14fa0b578bc5aa3215fa041f164fef4e76e54c3db8e79abd791ee1. ## Published Fact - US. Claim: alpha:claim:company:22376a27-8a83-4b7a-8170-d37004d7898f:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:f6234f630c14fa0b578bc5aa3215fa041f164fef4e76e54c3db8e79abd791ee1. ## Security Listing - MYGN (NASDAQ). Claim: alpha:claim:company:22376a27-8a83-4b7a-8170-d37004d7898f:security_listing:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:f6234f630c14fa0b578bc5aa3215fa041f164fef4e76e54c3db8e79abd791ee1. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:f6234f630c14fa0b578bc5aa3215fa041f164fef4e76e54c3db8e79abd791ee1: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/myriad-genetics-inc). - alpha:projection-evidence:document:66cadeead084c313c84f4fe86874042b9630b955c0d6588becc96c5330ebfd95: [SEC DEF 14A 0000899923-26-000031](https://www.sec.gov/Archives/edgar/data/899923/000089992326000031/mygn-20260414.htm). - alpha:projection-evidence:document:a34701cba6c5217b2482a87529b1b599d7c36452c134b499989193f1e64826e3: [DEF 14A mygn-20260414.htm](https://www.sec.gov/Archives/edgar/data/899923/000089992326000031/mygn-20260414.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/myriad-genetics-inc) - [Public Markdown](https://registry.alpha.ac/companies/myriad-genetics-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/myriad-genetics-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/myriad-genetics-inc?format=jsonld) - MCP resource: `alpha://companies/myriad-genetics-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-26T19:37:57.373905+00:00; recorded 2026-10-26T19:37:57.373905+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.